Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kiniksa Pharmaceuticals International, plc
With
Kiniksa Pharmaceuticals (UK), Ltd.
Age
7–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ACTIVE RP PATIENTS
Physician-confirmed (or confirmation in medical records) diagnosis of RP defined as an initial, acute, episode and at least one pericarditis recurrence after the initial acute episode
Experienced at least one pericarditis episode in the 3 years prior to inclusion
Under the care of a physician for the treatment and management of RP
Currently prescribed medication for RP
Physician-confirmed (or confirmation in medical records) diagnosis of RP defined as an initial, acute, episode and at least one pericarditis recurrence after the initial, acute episode
Patient had a last episode occurring at least 3 years and up to 5 years before registry inclusion
Resolution of RP symptoms confirmed with no further RP treatment for 3 years prior to registry enrollment
You may not be if
Diagnosis of pericarditis secondary to tuberculosis (TB), cancer if not in full remission, post thoracic blunt trauma (e.g., motor-vehicle accidents), myocarditis, systemic autoimmune diseases, except SJIA and adult Still's disease, HIV
Appears to have an impairment (e.g., cognitive, hearing, visual) or insufficient English or Spanish proficiency that could interfere with ability to complete patient-completed assessments
Currently enrolled in a therapeutic investigational drug or device study
INACTIVE RP PATIENTS
Experienced a pericarditis episode within 3 years from enrolling in the registry
Currently receiving RP treatment prescribed by a treating physician (e.g., CS, colchicine)
Diagnosis of pericarditis secondary to tuberculosis (TB), cancer if not in full remission, post thoracic blunt trauma (e.g., motor-vehicle accidents), myocarditis, systemic autoimmune diseases except SJIA and adult Still's disease, HIV
Enrolled in a therapeutic investigational clinical trial during the observation period
